Related Experiment Video
Updated: Jul 13, 2026

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
Distinct ErbB-2 coupled signaling pathways promote mammary tumors with unique pathologic and transcriptional profiles
Babette Schade1, Sonya H L Lam, Daniela Cernea
1Molecular Oncology Group, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
Abstract:
ErbB-2 overexpression and amplification occurs in 15% to 30% of human invasive breast carcinomas associated with poor clinical prognosis. Previously, we have shown that four ErbB-2/Neu tyrosine-autophosphorylation sites within the cytoplasmic tail of the receptor recruit distinct adaptor proteins and are sufficient to mediate transforming signals in vitro. Two of these sites, representing the growth factor receptor binding protein 2 (Grb2; Neu-YB) and the Src homology and collagen (Shc; Neu-YD) binding sites, can induce mammary tumorigenesis and metastasis. Here, we show that transgenic mice bearing the two other ErbB-2 autophosphorylation sites (Neu-YC and Neu-YE) develop metastatic mammary tumors. A detailed comparison of biological profiles among all Neu mutant mouse models revealed that Neu-YC, Neu-YD, and Neu-YE mammary tumors shared similar pathologic and transcriptional features. By contrast, the Neu-YB mouse model displayed a unique pathology with a high metastatic potential that correlates with a distinct transcriptional profile, including genes that promote malignant tumor progression such as metalloproteinases and chemokines. Furthermore, Neu-YB tumor epithelial cells showed abundant intracellular protein level of the chemokine CXCL12/SDF-1alpha, which may reflect the aggressive nature of this Neu mutant mouse model. Taken together, these findings indicate that activation of distinct Neu-coupled signaling pathways has an important impact on the biological behavior of Neu-induced tumors.
Insights
Different ErbB-2 signaling pathways impact breast cancer progression. The Neu-YB pathway drives aggressive, metastatic tumors with unique gene expression, unlike other ErbB-2 sites.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- ErbB-2 (Human Epidermal growth factor Receptor 2) overexpression is common in breast cancer, linked to poor prognosis.
- Specific tyrosine-autophosphorylation sites in ErbB-2's cytoplasmic tail recruit different adaptor proteins and mediate transforming signals.
- Previous studies identified growth factor receptor binding protein 2 (Grb2; Neu-YB) and Src homology and collagen (Shc; Neu-YD) binding sites as inducers of mammary tumorigenesis and metastasis.
Purpose of the Study:
- To investigate the role of the remaining two ErbB-2 autophosphorylation sites (Neu-YC and Neu-YE) in mammary tumor development.
- To compare the biological and transcriptional profiles of mouse models with different ErbB-2 autophosphorylation site mutations.
Main Methods:
- Generation of transgenic mouse models expressing specific ErbB-2 autophosphorylation site mutants (Neu-YC, Neu-YE, Neu-YB).
- Pathological and transcriptional analysis of mammary tumors developed in these mouse models.
- Comparison of gene expression profiles, focusing on genes associated with tumor progression.
Main Results:
- Transgenic mice with Neu-YC and Neu-YE sites developed metastatic mammary tumors with shared pathological and transcriptional features.
- The Neu-YB mouse model exhibited unique pathology and high metastatic potential, associated with a distinct transcriptional profile.
- Upregulated genes in Neu-YB tumors included metalloproteinases and chemokines, promoting malignant progression.
- Neu-YB tumor cells showed high intracellular levels of chemokine CXCL12/SDF-1alpha, suggesting aggressive behavior.
Conclusions:
- Distinct ErbB-2 autophosphorylation sites activate different signaling pathways.
- These distinct pathways significantly influence the biological behavior and metastatic potential of ErbB-2-induced mammary tumors.
- The Neu-YB pathway is particularly linked to aggressive tumor progression and metastasis in breast cancer models.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Master Transcription Regulators

